TAILIEUCHUNG - New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

Given the substantial findings in the area of control and cancer, it is important to explore the construct of control in greater depth. It has been argued (Shapiro, Schwartz, &Astin, 1996) that the relationship between control and health is not a simple linear one: “control is good, and the more control one has the better.”Acceptance (positive yielding) is a unique feature of control that is often overlooked in Western psychology (Shapiro & Astin, 1998), and yet, the literature demonstrates that acceptance is a crucial component in gaining an optimal sense of control. For example, Astin and colleagues (1999) found that women with breast cancer using a balanced. | EUROPEAN journal of cancer 45 2009 228-247 available at J ScienceDirect journal homepage New response evaluation criteria in solid tumours Revised RECIST guideline version . Eisenhauera P. Therasseb J. Bogaertsc . Schwartzd D. Sargent R. Fordf J. Danceyg S. Arbuckh S. Gwytheri M. Mooneyg L. Rubinsteing L. Shankarg L. Doddg R. Kaplanj D. Lacombec J. Verweijk National Cancer Institute of Canada - Clinical Trials Group 10 Stuart Street Queen s University Kingston ON Canada bGlaxoSmithKline Biologicals Rixensart Belgium European Organisation for Research and Treatment of Cancer Data Centre Brussels Belgium dMemorial Sloan Kettering Cancer Center New York NY USA eMayo Clinic Rochester MN USA fRadPharm Princeton NJ USA gDivision of Cancer Treatment and Diagnosis National Cancer Institute Bethesda MD USA hSchering-Plough Kenilworth NJ USA East Surrey Hospital Redhill Surrey UK jNational Cancer Research Network Leeds UK kErasmus University Medical Center Rotterdam The Netherlands ARTICLE INFO ABSTRACT Article history Received 17 October 2008 Accepted 29 October 2008 Keywords Response criteria Solid tumours Guidelines Background Assessment of the change in tumour burden is an important feature of the clinical evaluation of cancer therapeutics both tumour shrinkage objective response and disease progression are useful endpoints in clinical trials. Since RECIST was published in 2000 many investigators cooperative groups industry and government authorities have adopted these criteria in the assessment of treatment outcomes. However a number of questions and issues have arisen which have led to the development of a revised RECIST guideline version . Evidence for changes summarised in separate papers in this special issue has come from assessment of a large data warehouse 6500 patients simulation studies and literature reviews. Highlights of revised RECIST Major changes include Number of lesions to be assessed based on .

• Y học thường thức
• historical exposure
• New Possibilities
• Gamete Low
• Vitrification
• Canadian Experience
• Lethal Osmotic
• báo cáo khoa học
• báo cáo hóa học
• công trình nghiên cứu về hóa học
• tài liệu về hóa học
• cách trình bày báo cáo
• trình bày báo cáo
• tài liệu báo cáo khoa học
• nghiên cứu y học
• báo cáo y học
• kiến thức y học
• BMC Veterinary Research
• Mycoplasma bovis
• Food source
• Bacterial pathogen
• Reproductive disorders
• Temperature Storage
• Cryopreservation
• Human Spermatozoa
• Fire Resistance
• Features and Applications
• Natural Sources
• Composite Materials
• consultation document
• particular circumstances
• sufficient donors
• Vitrification Technique
• Researchers seeking